ITI Mutual FundHealthcareDirect plan, growth

ITI Pharma and Healthcare Fund

Compare healthcare funds Compare with others

NAV: ₹19.90; —11 Sept 2026
AUM (₹ Cr): 234; Average, April - June 2026
Expense ratio: 0.92%; Regular 2.62%
Risk: Very High; SEBI riskometer

1Y return: 11.9%-1.5%; Benchmark 13.4%
3Y CAGR: 19.8%-0.5%; Benchmark 20.3%
5Y CAGR: —; Category 15.6%

Loading NAV history…

ITI Pharma and Healthcare Fund

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
Fund	-0.2%	+8.8%	+20.9%	+16.6%	+11.9%	+19.8%	—	—	+15.3%
NIFTY Healthcare TRI	—	—	—	—	13.4%	20.3%	—	—	15.1%
Healthcare average	0.3%	9.6%	22.5%	20.0%	17.6%	21.7%	15.6%	15.0%	19.1%
Difference	—	—	—	—	-1.5%	-0.5%	—	—	+0.2%

Portfolio

Fund details

Fund house: ITI Mutual Fund
Category: Equity · Healthcare
SEBI classification: Equity / Sectoral / Thematic
Benchmark: NIFTY Healthcare TRI
Launch date: 11 Nov 2021 (4.8 years)
Structure: Open Ended
Plans and options: Direct Growth, Regular Growth
Fund manager: Animesh Singh
Minimum SIP: ₹500
Minimum lumpsum: ₹5,000 (then ₹1,000)
Exit load: 0.50%
Lock-in: None
Riskometer: Very High (benchmark Very High)
Expense ratio as of: 9 Sept 2026
AUM period: April - June 2026
ISIN, Direct Growth: INF00XX01BO9
ISIN, Regular Growth: INF00XX01BL5
Scheme code: 149268, 149270

NAV and returns as of 11 Sept 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other healthcare funds

Other funds in the Healthcare category.

Compare healthcare funds